Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
68 NC counties are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Closings
118 closings/delays reported, including Durham and Wake public schools.
Just In
Helene update: Category 4 storm continues gaining strength with 140 mph winds as it nears Florida. Tornado watches issued for southern NC counties
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by C2N Diagnostics, LLC
C2N Receives Funding from Diagnostics Accelerator to Develop a Decentralized Clinical Mass Spectrometry Solution to Enable High-Performance Alzheimer’s Disease Testing Worldwide
September 25, 2024
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together Innovation Leaders in Diagnostics and Laboratory Medicine to Advance Brain Health
August 07, 2024
From
C2N Diagnostics, LLC
Via
Business Wire
JAMA Publishes Landmark Clinical Study Showing C2N Diagnostics’ PrecivityAD2™ Blood Test Markedly Improves Accuracy of AD Diagnosis in Both Primary Care and Specialized Memory Care
July 28, 2024
From
C2N Diagnostics, LLC
Via
Business Wire
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
June 27, 2024
From
C2N Diagnostics, LLC
Via
Business Wire
C₂N Diagnostics, LLC Announces Investment From Eisai Inc.
March 06, 2024
From
C2N Diagnostics, LLC
Via
Business Wire
Researchers Identify New Cost Savings and Accuracy of C2N Diagnostics’ Blood Tests to Enable Healthcare Providers to Better Identify Alzheimer’s Disease
November 16, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid in Pre-Clinical Alzheimer's Disease
November 07, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics Introduces Next-Generation Fluid Biomarker to the Field of Alzheimer’s Disease: Test to Help Researchers Track Neurofibrillary “Tau” Tangle Pathology
October 25, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
On World Alzheimer’s Day, C2N Diagnostics’ PrecivityAD2™ Blood Test Expands Reach
September 21, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF
August 17, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
Real-World Evidence Shows Healthcare Providers Use C2N Diagnostics’ PrecivityAD® Blood Test to Help Affirm Alzheimer’s Disease Diagnosis and Change Drug Treatment Decisions
August 08, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
C2N’s PrecivityAD® Blood Test, Which Identifies Amyloid Pathology as an Aid to Alzheimer’s Disease Diagnosis, Further Demonstrates Its High Accuracy in Newly Published Research
March 29, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics Announces Follow-on Investment from GHR Foundation as It Builds on Success in Novel Diagnostics to Aid in Alzheimer’s Disease Fight
February 16, 2023
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics’ PrecivityAD® and PrecivityAD2™ Blood Tests at CTAD 2022 Highlight the Potential and Use of Blood-Based Biomarkers in the Diagnosis of Alzheimer’s Disease
December 09, 2022
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Diagnostics Introduces the PrecivityAD2™ Blood Test
November 29, 2022
From
C2N Diagnostics, LLC
Via
Business Wire
C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments
October 21, 2022
From
C2N Diagnostics, LLC
Via
Business Wire
Independent Research Finds Underlying Method for C2N’s p-Tau217 Ratio Blood Test Outperforms Other Tau Blood Tests Used for Alzheimer’s Diagnoses
September 14, 2022
From
C2N Diagnostics, LLC
Via
Business Wire
C2N Begins New Year with CAP Accreditation Award, the Highest Standard in Laboratory Practices
January 03, 2022
From
C2N Diagnostics, LLC
Via
Business Wire
Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis
November 12, 2021
From
C2N Diagnostics, LLC
Via
Business Wire
Peer-Reviewed Journal Publishes PrecivityAD™ Blood Test Research, Confirming Its Role in Assisting Clinicians in Alzheimer’s Diagnosis
May 05, 2021
From
C2N Diagnostics, LLC
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.